| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 877 |
| 1 | VEDOLIZUMAB | 295 |
| 2 | INFLIXIMAB | 276 |
| 3 | PREDNISONE | 199 |
| 4 | AZATHIOPRINE | 196 |
| 5 | METHOTREXATE SODIUM | 143 |
| 6 | METHOTREXATE | 129 |
| 7 | ADALIMUMAB-ADAZ | 120 |
| 8 | USTEKINUMAB | 119 |
| 9 | ADALIMUMAB-AATY | 116 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFOTETAN DISODIUM | 1 | 0.0089 |
| 1 | ADALIMUMAB-AACF | 2 | 0.0060 |
| 2 | LULICONAZOLE | 1 | 0.0057 |
| 3 | SEVELAMER HYDROCHLORIDE | 2 | 0.0035 |
| 4 | VEDOLIZUMAB | 295 | 0.0034 |
| 5 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 6 | SORBITOL | 2 | 0.0033 |
| 7 | NITAZOXANIDE | 1 | 0.0029 |
| 8 | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | 1 | 0.0027 |
| 9 | ADALIMUMAB-FKJP | 114 | 0.0025 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 358 |
| 1 | Corticosteroid [EPC] | 327 |
| 2 | Integrin Receptor Antagonist [EPC] | 295 |
| 3 | Purine Antimetabolite [EPC] | 196 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 158 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 134 |
| 6 | Interleukin-23 Antagonist [EPC] | 120 |
| 7 | Interleukin-12 Antagonist [EPC] | 119 |
| 8 | Vitamin C [EPC] | 94 |
| 9 | Vitamin B12 [EPC] | 80 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 295 | 0.0034 |
| 1 | Purine Antimetabolite [EPC] | 196 | 0.0020 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 3 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 4 | Selective T Cell Costimulation Blocker [EPC] | 6 | 0.0013 |
| 5 | Interleukin-12 Antagonist [EPC] | 119 | 0.0011 |
| 6 | Interleukin-23 Antagonist [EPC] | 120 | 0.0011 |
| 7 | Bile Acid Sequestrant [EPC] | 11 | 0.0009 |
| 8 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 9 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |